Crossmark

COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review

Crossref DOI link: https://doi.org/10.1007/s13205-021-03076-0

Published Online: 2021-12-12

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Simnani, Faizan Zarreen https://orcid.org/0000-0002-6041-0234
Singh, Dibyangshee

Kaur, Ramneet
License Information

Text and Data Mining valid from 2021-12-12

Version of Record valid from 2021-12-12
More Information

Article History

Received: 18 June 2021

Accepted: 26 November 2021

First Online: 12 December 2021

Declarations

:

: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below